Patent 11970539 was granted and assigned to Ichnos Sciences on April, 2024 by the United States Patent and Trademark Office.
The present invention relates to antibodies which specifically bind to human IL1RAP and may also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.